久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

J&J fined $572m for role in US opioid crisis

By HENG WEILI in New York | China Daily Global | Updated: 2019-08-27 23:44
Share
Share - WeChat
A logo sign outside of a facility occupied by Johnson & Johnson in Irvine, California on Dec 9, 2017. [Photo/IC]

The opioid epidemic in the United States has claimed many victims, and a major pharmaceutical company was told Monday that it will be paying a hefty price for its involvement.

An Oklahoma judge determined that Johnson & Johnson was liable for fueling an opioid epidemic in the south central US state by deceptively marketing addictive painkillers and ordered the New Jersey-based drugmaker to pay $572.1 million.

Opioids were involved in almost 400,000 overdose deaths from 1999 to 2017, according to the US Centers for Disease Control and Prevention.

Since 2000, some 6,000 Oklahomans have died from opioid overdoses, according to the state's lawyers.

The trial came about after Oklahoma had resolved claims against OxyContin maker Purdue Pharma LP in March for $270 million and against Teva in May for $85 million, leaving J&J as the lone defendant.

Lawyers for Oklahoma argued that J&J— the first opioid maker to face trial — carried out a years-long marketing campaign that minimized the painkillers' addiction risks and promoted their benefits.

The state's witnesses cited statistics showing that enough opioids were dispensed in 2017 for every adult in Oklahoma to be given the equivalent of 156 hydrocodone 10 milligram tablets, according to The Oklahoman website.

Still, the award was well below what some investors and analysts feared, in what had been a $17 billion lawsuit viewed as a bellwether for other litigation nationwide over the opioid crisis.

"The expectation was this was going to be a $1.5 billion to $2 billion fine," said Jared Holz, healthcare strategist for Jefferies, adding that the $572 million "is a much lower number than had been feared".

As a result, J&J shares rose in after-hours trading.

J&J, the No. 37 company in the Fortune 500, said it would appeal to the Oklahoma Supreme Court and will look to put the award payment on hold.

"Janssen (a subsidiary of J&J) did not cause the opioid crisis in Oklahoma, and neither the facts nor the law support this outcome," Michael Ullmann, J&J's general counsel, said in a statement.

The decision by Judge Thad Balkman of Cleveland County District Court in Norman, Oklahoma, followed a seven-week non-jury trial.

The case brought by Oklahoma Attorney General Mike Hunter was the first to go to trial out of thousands of lawsuits filed by state and local governments against opioid manufacturers and distributors.

Oklahoma argued that J&J's marketing practices helped fuel the opioid epidemic by flooding the market with painkillers.

"Johnson & Johnson will finally be held accountable for thousands of deaths and addictions caused by their actions," Hunter said.

The attorney general has said that between 2015 and 2018, 18 million opioid prescriptions were written in Oklahoma, a state with around 4 million people.

Hunter said J&J "embarked on a cynical, deceitful, multibillion-dollar brainwashing campaign to establish opioid analgesics as the magic drug."

J&J has denied wrongdoing, saying its marketing claims had scientific support and that its painkillers, Duragesic and Nucynta, accounted for a small fraction of opioids prescribed in Oklahoma.

Ullmann faulted Oklahoma for attempting a "misapplication of public nuisance law" that judges in other states had already rejected.

Oklahoma sued J&J to help it address the epidemic for the next 30 years through treatment and prevention programs.

But the judge said the figure he awarded covered only one year, saying Oklahoma did not offer enough evidence of the time and costs to address the opioid crisis beyond that.

The litigation has been closely watched by plaintiffs in about 2,000 opioid lawsuits pending before a federal judge in Ohio.

Reuters contributed to this story.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 被老外玩爽的中国美女视频 | 国产精品怡红院在线观看 | 国产一区亚洲二区三区毛片 | 国内黄色精品 | 亚洲国产精品久久 | 国产美女在线精品观看 | 久久午夜鲁丝片午夜精品 | 亚洲精品国产福利片 | 亚洲国产精品自产拍在线播放 | 偷拍自拍日韩 | 成年免费a级毛片 | 成年人免费在线观看网站 | 免费看美女无遮掩的软件 | 男人天堂视频在线观看 | 亚洲综合干 | 欧美成人手机视频免费播放 | 日韩一级欧美一级毛片在线 | 黄色片日本人 | 欧美在线高清 | 欧美一级视频在线 | 特黄特级a级黄毛片免费观看多人 | 香蕉久久夜色精品国产 | 在线视频观看一区 | 免费看一级欧美毛片视频 | 欧美国产日韩一区二区三区 | 久久久这里只有精品加勒比 | 九九国产视频 | 欧美国产日韩在线观看 | 久久久小视频 | 欧美性猛交xxxxxxxx软件 | 精品特级一级毛片免费观看 | 国产亚洲欧美日韩国产片 | 亚洲国产日韩欧美在线 | 午夜宅男在线永久免费观看网 | 欧美日韩一级二级三级 | 国内精品美女写真视频 | 99热久久国产综合精品久久国产 | 欧美在线国产 | 日韩在线视屏 | 欧美aaaaaabbbbb| 国产精品福利午夜h视频 |